vs

Side-by-side financial comparison of Nordson Corporation (NDSN) and Real Brokerage Inc (REAX). Click either name above to swap in a different company.

Nordson Corporation is the larger business by last-quarter revenue ($669.5M vs $568.5M, roughly 1.2× Real Brokerage Inc). Nordson Corporation runs the higher net margin — 19.9% vs -0.1%, a 20.0% gap on every dollar of revenue. On growth, Real Brokerage Inc posted the faster year-over-year revenue change (52.6% vs 8.8%). Nordson Corporation produced more free cash flow last quarter ($122.9M vs $8.4M).

Nordson Corporation is an American multinational corporation that designs and manufactures dispensing equipment for consumer and industrial adhesives, sealants and coatings. The company also manufactures equipment used in the testing and inspection of electronic components, technology-based systems for curing and surface treatment processes as well as medical devices and component technologies.

Anywhere Real Estate Inc., formerly Realogy, was an American real estate services firm. It operated and franchised real estate brands that provided brokerage, relocation, title, insurance, and settlement services. Brands included Better Homes and Gardens Real Estate, Century 21 Real Estate, Coldwell Banker, Corcoran Group, ERA Real Estate and Sotheby's International Realty. In 2026, the company was acquired by Compass, Inc.

NDSN vs REAX — Head-to-Head

Bigger by revenue
NDSN
NDSN
1.2× larger
NDSN
$669.5M
$568.5M
REAX
Growing faster (revenue YoY)
REAX
REAX
+43.9% gap
REAX
52.6%
8.8%
NDSN
Higher net margin
NDSN
NDSN
20.0% more per $
NDSN
19.9%
-0.1%
REAX
More free cash flow
NDSN
NDSN
$114.5M more FCF
NDSN
$122.9M
$8.4M
REAX

Income Statement — Q1 FY2027 vs Q3 FY2025

Metric
NDSN
NDSN
REAX
REAX
Revenue
$669.5M
$568.5M
Net Profit
$133.4M
$-447.0K
Gross Margin
54.7%
7.9%
Operating Margin
24.9%
-0.1%
Net Margin
19.9%
-0.1%
Revenue YoY
8.8%
52.6%
Net Profit YoY
40.9%
82.7%
EPS (diluted)
$2.38
$0.00

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NDSN
NDSN
REAX
REAX
Q4 26
$669.5M
Q4 25
$751.8M
Q3 25
$741.5M
$568.5M
Q2 25
$682.9M
$540.7M
Q1 25
$615.4M
$354.0M
Q4 24
$744.5M
Q3 24
$661.6M
$372.5M
Q2 24
$650.6M
Net Profit
NDSN
NDSN
REAX
REAX
Q4 26
$133.4M
Q4 25
$151.6M
Q3 25
$125.8M
$-447.0K
Q2 25
$112.4M
$1.5M
Q1 25
$94.7M
$-5.0M
Q4 24
$122.2M
Q3 24
$117.3M
$-2.6M
Q2 24
$118.2M
Gross Margin
NDSN
NDSN
REAX
REAX
Q4 26
54.7%
Q4 25
56.3%
Q3 25
54.8%
7.9%
Q2 25
54.7%
8.9%
Q1 25
54.6%
9.6%
Q4 24
54.1%
Q3 24
55.8%
8.6%
Q2 24
56.2%
Operating Margin
NDSN
NDSN
REAX
REAX
Q4 26
24.9%
Q4 25
28.5%
Q3 25
25.3%
-0.1%
Q2 25
24.7%
0.3%
Q1 25
22.9%
-1.5%
Q4 24
24.0%
Q3 24
25.3%
-0.7%
Q2 24
25.9%
Net Margin
NDSN
NDSN
REAX
REAX
Q4 26
19.9%
Q4 25
20.2%
Q3 25
17.0%
-0.1%
Q2 25
16.5%
0.3%
Q1 25
15.4%
-1.4%
Q4 24
16.4%
Q3 24
17.7%
-0.7%
Q2 24
18.2%
EPS (diluted)
NDSN
NDSN
REAX
REAX
Q4 26
$2.38
Q4 25
$2.67
Q3 25
$2.22
$0.00
Q2 25
$1.97
$0.01
Q1 25
$1.65
$-0.02
Q4 24
$2.12
Q3 24
$2.04
$-0.01
Q2 24
$2.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NDSN
NDSN
REAX
REAX
Cash + ST InvestmentsLiquidity on hand
$120.4M
$38.7M
Total DebtLower is stronger
$1.9B
Stockholders' EquityBook value
$3.1B
$53.6M
Total Assets
$145.2M
Debt / EquityLower = less leverage
0.62×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NDSN
NDSN
REAX
REAX
Q4 26
$120.4M
Q4 25
$108.4M
Q3 25
$147.8M
$38.7M
Q2 25
$130.2M
$49.7M
Q1 25
$130.4M
$24.7M
Q4 24
$116.0M
Q3 24
$165.3M
$22.6M
Q2 24
$125.4M
Total Debt
NDSN
NDSN
REAX
REAX
Q4 26
$1.9B
Q4 25
$2.0B
Q3 25
$2.1B
Q2 25
$2.2B
Q1 25
$2.2B
Q4 24
$2.2B
Q3 24
$1.5B
Q2 24
$1.5B
Stockholders' Equity
NDSN
NDSN
REAX
REAX
Q4 26
$3.1B
Q4 25
$3.0B
Q3 25
$3.0B
$53.6M
Q2 25
$3.0B
$49.2M
Q1 25
$2.9B
$32.8M
Q4 24
$2.9B
Q3 24
$2.9B
$29.8M
Q2 24
$2.8B
Total Assets
NDSN
NDSN
REAX
REAX
Q4 26
Q4 25
$5.9B
Q3 25
$6.0B
$145.2M
Q2 25
$6.1B
$149.4M
Q1 25
$5.9B
$100.5M
Q4 24
$6.0B
Q3 24
$5.2B
$102.5M
Q2 24
$5.2B
Debt / Equity
NDSN
NDSN
REAX
REAX
Q4 26
0.62×
Q4 25
0.66×
Q3 25
0.71×
Q2 25
0.74×
Q1 25
0.75×
Q4 24
0.75×
Q3 24
0.52×
Q2 24
0.55×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NDSN
NDSN
REAX
REAX
Operating Cash FlowLast quarter
$140.4M
$8.8M
Free Cash FlowOCF − Capex
$122.9M
$8.4M
FCF MarginFCF / Revenue
18.4%
1.5%
Capex IntensityCapex / Revenue
0.1%
Cash ConversionOCF / Net Profit
1.05×
TTM Free Cash FlowTrailing 4 quarters
$646.3M
$71.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NDSN
NDSN
REAX
REAX
Q4 26
$140.4M
Q4 25
$202.9M
Q3 25
$238.0M
$8.8M
Q2 25
$119.2M
$41.0M
Q1 25
$159.1M
$15.9M
Q4 24
$96.4M
Q3 24
$164.8M
$7.2M
Q2 24
$122.6M
Free Cash Flow
NDSN
NDSN
REAX
REAX
Q4 26
$122.9M
Q4 25
$193.9M
Q3 25
$226.4M
$8.4M
Q2 25
$103.1M
$40.8M
Q1 25
$137.7M
$15.7M
Q4 24
$75.8M
Q3 24
$143.0M
$6.8M
Q2 24
$108.2M
FCF Margin
NDSN
NDSN
REAX
REAX
Q4 26
18.4%
Q4 25
25.8%
Q3 25
30.5%
1.5%
Q2 25
15.1%
7.5%
Q1 25
22.4%
4.4%
Q4 24
10.2%
Q3 24
21.6%
1.8%
Q2 24
16.6%
Capex Intensity
NDSN
NDSN
REAX
REAX
Q4 26
Q4 25
1.2%
Q3 25
1.6%
0.1%
Q2 25
2.3%
0.0%
Q1 25
3.5%
0.1%
Q4 24
2.8%
Q3 24
3.3%
0.1%
Q2 24
2.2%
Cash Conversion
NDSN
NDSN
REAX
REAX
Q4 26
1.05×
Q4 25
1.34×
Q3 25
1.89×
Q2 25
1.06×
27.13×
Q1 25
1.68×
Q4 24
0.79×
Q3 24
1.41×
Q2 24
1.04×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

NDSN
NDSN

Industrial Precision Solutions$326.9M49%
Medical and Fluid Solutions$193.2M29%
Advanced Technology Solutions$149.4M22%

REAX
REAX

Segment breakdown not available.

Related Comparisons